Biotech

All Articles

Angelini pens $360M biobucks contract for ph. 1 mind disorder medication

.Italy's Angelini Pharma has signed a $360 thousand biobucks pact fixated a phase 1-stage human brai...

Sage gives up half of R&ampD staff and also shocks C-suite again

.Sage Therapies' most recent effort to reduce its own pipeline as well as workforce will view a thir...

With period 1 data, Atmosphere possesses an eye on early-stage sac cancer cells

.With its own lead candidate in a stage 3 trial for an unusual eye cancer cells, Mood Biosciences is...

Less than a year in, BenevolentAI CEO is actually out-- Chutes &amp Ladders

.Welcome to this week's Chutes &amp Ladders, our summary of considerable management hirings, shootin...

Roche MAGE-A4 trial removed after tactical review

.Roche has actually made yet another MAGE-A4 program go away, taking out a phase 1 test of a T-cell ...

FDA places partial hold on BioNTech-OncoC4 stage 3 test

.The FDA has actually implemented a predisposed hang on a stage 3 non-small tissue bronchi cancer ce...

REGiMMUNE, Kiji merge to make Treg 'incredibly business,' plan IPO

.Taiwan's REGiMMUNE and also Europe-based Kiji Rehabs are merging to create a globally minded regula...

With trial succeed, Merck looks to tackle Sanofi, AZ in RSV

.Three months after uncovering that its own breathing syncytial infection (RSV) preventative antitox...

Noema ticks off phase 2a Tourette gain for ex-Roche molecule

.Noema Pharma has racked up a phase 2a gain for its Tourette disorder medication applicant, disclosi...

Terray assembles $120M collection B to breakthrough AI-powered particles

.Terray Therapies has brought in $120 thousand for a collection B fundraise as the AI-focused biotec...